Antiviral therapy with nucleotide/nucleoside analogues indications are generally provided to individuals at a high risk of disease progression, namely those with elevated ALT levels, active viral replication, and advanced fibrosis or cirrhosis.5 This evidence concerns the gene GPT and Cirrhosis.